Cited in UK press coverage of health & social care
2 citations
Across 1 topic, first on 27 Aug 2026.
Biography
Rebecca L. Siegel, MPH, is a cancer epidemiologist and Senior Scientific Director of Surveillance Research at the American Cancer Society. She leads the ACS Surveillance Research programme, directing the production of seven Facts & Figures publications and their accompanying scientific articles. She is the lead author of the annual Cancer Statistics and annual Colorectal Cancer Statistics reports published in CA: A Cancer Journal for Clinicians, regarded as the gold-standard source of US cancer burden data. Her research focuses on disparities in cancer incidence and mortality, with particular emphasis on colorectal cancer and early-onset disease. Her work contributed to the American Cancer Society's decision to lower its recommended colorectal cancer screening age from 50 to 45. She serves as a scientific advisor on research initiatives in that area.
References
- 1.Rebecca Siegel, MPH | American Cancer Society Researchers — Current role title (Senior Scientific Director, Surveillance Research), leadership of the ACS Surveillance Research programme, lead authorship of annual statistics reports, colorectal cancer focus and contribution to screening age change.
- 2.Annual Cancer Statistics Report 2026 – ACS Press Room — Confirms her role as lead author of the 2026 Cancer Statistics report and the 70% five-year survival milestone finding.
- 3.Cancer statistics, 2025 – CA: A Cancer Journal for Clinicians — Confirms ORCID (0000-0001-5247-8522), institutional affiliation, and Atlanta correspondence address (270 Peachtree Street NW, Suite 1300, Atlanta, GA 30303).
- 4.Cancer statistics, 2026 – CA: A Cancer Journal for Clinicians — Confirms lead/corresponding authorship on the most recent annual report and her unit (Surveillance, Prevention, and Health Services Research) at ACS, Atlanta.
- 5.
Expertise
Cited on
Stated areas of expertise
- Cancer surveillance and statistics
- Colorectal cancer epidemiology
- Early-onset cancer trends
- Cancer screening policy
- Cancer disparities and inequalities
- Cancer mortality and survival trends
Notable achievements
- Lead author of Cancer Statistics, 2026, reporting that the five-year relative survival rate for all cancers combined reached 70% for the first time. Source ↗
- Her research contributed to the American Cancer Society lowering its recommended colorectal cancer screening age from 50 to 45. Source ↗
- Corresponding author on annual Cancer Statistics reports published in CA: A Cancer Journal for Clinicians continuously from at least 2020 through 2026. Source ↗
What they’ve said
“Around three-quarters of people under 50 already have advanced colorectal cancer when they're diagnosed, 'because they haven't been screened through regular colonoscopies, and they don't take their symptoms seriously, because they think they're too young'.”
epidemiologist and senior director of cancer surveillance research at the American Cancer Society · Cancer · 27 Aug 2026 · Colon cancer now leading cause of cancer deaths under 50 in US ↗
“People were saying the risk was too low. We were going to take screening away from older adults who have a higher burden, and we were going to exacerbate disparities, because young people were going to be taking screening away from people of color”
epidemiologist at the American Cancer Society · Cancer · 27 Aug 2026 · US under-45s struggle for insurance approval as colon cancer rates rise ↗
Source references
- Colon cancer now leading cause of cancer deaths under 50 in UStheguardian.com · 27 Aug 2026
- US under-45s struggle for insurance approval as colon cancer rates risetheguardian.com · 27 Aug 2026
Contact & links
- Staff pagehttps://www.cancer.org/research/acs-researchers/rebecca-siegel-bio.html
- ORCIDhttps://orcid.org/0000-0001-5247-8522published here ↗
- LinkedInhttps://www.linkedin.com/in/rebecca-siegel-2a851a40/published here ↗
Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.